Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Auditory Control Network With Auditory Control Enhancement (ACE) in Schizophrenia

NCT06155695 is registered in ClinicalTrials.gov with Brian A Coffman, PhD as lead sponsor.

NCT NCT06155695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06155695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Auditory Control Network With Auditory Control Enhancement (ACE) in Schizophrenia
Lead sponsor
Brian A Coffman, PhD
Phase
Not applicable
Overall status
Terminated
Start date
September 5, 2023
Completion date
December 18, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

auditory hallucinations